These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21574973)

  • 21. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B.
    Cao J; Zhang L; Huang S; Chen P; Zou L; Chen H; Xiang Y; Lai X; Ren G
    Microb Pathog; 2011 Oct; 51(4):262-7. PubMed ID: 21736935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome.
    Zhou Q; Xiao X; Wang C; Zhang X; Li F; Zhou Y; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5665-74. PubMed ID: 22815348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
    Liu X; Wang C; Ye Z; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: lack of correlation with T-cell hyporesponsiveness.
    Cacere CR; Mendes-Giannini MJ; Fontes CJ; Kono A; Duarte AJ; Benard G
    Clin Immunol; 2008 Nov; 129(2):341-9. PubMed ID: 18757242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1).
    Achleitner A; Clark ME; Bienzle D
    Vet Immunol Immunopathol; 2011 Oct; 143(3-4):307-13. PubMed ID: 21719113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
    Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
    Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.
    Norde WJ; Maas F; Hobo W; Korman A; Quigley M; Kester MG; Hebeda K; Falkenburg JH; Schaap N; de Witte TM; van der Voort R; Dolstra H
    Cancer Res; 2011 Aug; 71(15):5111-22. PubMed ID: 21659460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
    Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
    Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
    Saverino D; Brizzolara R; Simone R; Chiappori A; Milintenda-Floriani F; Pesce G; Bagnasco M
    Clin Immunol; 2007 May; 123(2):190-8. PubMed ID: 17321799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers.
    Bank I; Duvdevani M; Livneh A
    J Lab Clin Med; 2003 Jan; 141(1):33-40. PubMed ID: 12518166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.
    Aarslev K; Dige A; Greisen SR; Kreutzfeldt M; Jessen N; Vilstrup H; Deleuran B; Grønbæk H
    Scand J Gastroenterol; 2017 Jan; 52(1):93-99. PubMed ID: 27604386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.
    Wiesemann E; Deb M; Trebst C; Hemmer B; Stangel M; Windhagen A
    Mult Scler; 2008 Mar; 14(2):166-76. PubMed ID: 17942524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY; Park MJ; Park S; Lee ES
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
    Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
    Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.